A baby in the US is among the first people with a rare genetic disorder to be treated with CRISPR, a customised gene-editing therapy that allows scientists to edit DNA.
The baby, known as KJ, was diagnosed soon after his birth with a rare disorder called severe carbamoyl-phosphate synthetase 1 deficiency (CPS1), which is estimated to affect about one in a million babies.
